COVID-19
Top in ID: CDC resumes journal publication; concerns rise over removal of health resources
Last week the CDC published Morbidity and Mortality Weekly Report for the first time since the Trump administration froze public communications from various national health agencies.
On its 5th anniversary, experts address questions about COVID-19
In 5 years, COVID-19 has impacted nearly every aspect of life. Although tens of thousands of cases continue to occur each week, the world’s top public health agencies have considered the pandemic phase of COVID-19 to be over for years.
COVID-19-causing virus linked to coronary plaque progression, risk for MI, death
SARS-CoV-2 infection was associated with more rapid coronary plaque progression and significantly increased risk for adverse outcomes related to target lesion failure, such as heart attack and death, researchers reported.
Rising deaths in early-aged adults suggests ‘possibility of a worsening mortality crisis’
Mortality among adults aged 25 to 44 years rose significantly between 2011 and 2023 compared with trends in the early 2000s, results from a cross-sectional study showed.
‘Healthy skepticism,’ shifting protocols may fuel COVID-19 vaccine hesitancy, fatigue
Inconsistent messaging and evolving recommendations surrounding COVID-19 vaccination protocols may have contributed to both hesitancy and fatigue regarding vaccines among patients, according to experts.
Decentralized clinical trials: FDA guidance and the ‘new modus operandi’
The COVID-19 pandemic forced investigators conducting clinical trials to use decentralized elements, such as telehealth, to continue their research.
‘Striking’ finding: MicroRNA may predict COVID-19 mortality risk among people with cancer
Researchers have identified two microRNA that may predict which individuals with cancer are at elevated risk for COVID-19-related death.
Pemivibart only option against ‘false reassurance’ of reduced SARS-CoV-2 virulence
The next phase of pre-exposure prophylaxis against SARS-CoV-2 currently rests on the shoulders of a single monoclonal antibody product — but it may not be enough for immunocompromised populations.
Severity of MIS-C fell over time, and most children recovered within 6 months
The severity of multisystem inflammatory syndrome in children decreased as the COVID-19 pandemic went on, and most children recovered to their preinfection health within 6 months, according to two recent studies.
COVID's role in autoimmunity and where we are in the world of long COVID
On this episode, hear the 2024 updates on COVID-19, long COVID and the latest developments in research in rheumatology. Hosted by Dr. Leonard Calabrese.